| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Idarubicin | Idarubicin Aglycone | VE009561 | View CAS 60660-75-5 |
Idarubicin Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Idarubicin | Idarubicin Aglycone | VE009561 | View CAS 60660-75-5 |
| Catalogue No. | VE009561 |
| CAS No. | 60660-75-5 |
| Molecular Formula | C20H16O7 |
| Molecular Weight | 368.33 g/mol |
| Parent drug | Idarubicin |
| IUPAC Name | (7S, 9S)-9-acetyl-6, 7, 9, 11-tetrahydroxy-7, 8, 9, 10-tetrahydrotetracene-5, 12-dione |
| Synonyms | Idarubicinone/ 4-Demethoxydaunomycinone |
| References | Wang, H., Xiao, X., Xiao, Q., Lu, Y., & Wu, Y. (2020). The efficacy and safety of daunorubicin versus idarubicin combined with cytarabine for induction therapy in acute myeloid leukemia. Medicine, 99(24), e20094. https://doi.org/10.1097/md.0000000000020094 |
| Status | In-stock |
| ListName | Idarubicin Aglycone |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
